
METiS Therapeuticsrevenue & acquisition
Clinical Research SoftwareCambridge, Massachusetts
METiS Therapeutics was acquired.
METiS, founded by a team of MIT researchers, serial entrepreneurs, and biotech industry veterans, develops and in-licenses novel assets with high therapeutic potential to leverage its data-driven platform for advancements in the field.
METiS Therapeutics revenue
METiS Therapeutics has not published its revenue. Growjo puts it at about $3.7M a year (December 2023).
| As of | Revenue | Source |
|---|---|---|
| Dec 2023 | $3.7MEST | Growjo estimate |
Who owns METiS Therapeutics
Another company owns METiS Therapeutics. The date and price of the deal are not on record.
METiS Therapeutics CEO, founders & employees
Wenshou Wang founded METiS Therapeutics and led it as CEO. METiS Therapeutics had 38 employees (December 2023, Growjo estimate).
- Wenshou WangFounder & CEO
All 2 headcount readings, with sources
| As of | Employees | Source |
|---|---|---|
| Dec 2023 | 38EST | Growjo estimate |
| Dec 2022 | 32EST | Growjo estimate |
METiS Therapeutics FAQ
What was METiS Therapeutics' revenue?
Growjo estimates METiS Therapeutics' revenue at about $3.7M a year (December 2023). The company hasn't published its own figure.
How many employees does METiS Therapeutics have?
Growjo estimates METiS Therapeutics' headcount at about 38 (December 2023).
Who founded METiS Therapeutics?
Wenshou Wang founded METiS Therapeutics.
Browse Clinical Research Software
How this page is sourced
3 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Oct 5, 2026Data disclaimerReport a correctionClaim this profileRun METiS Therapeutics? Join the podcast